Design, synthesis, DNA binding, and biological evaluation of water-solublehybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders
Pg. Baraldi et al., Design, synthesis, DNA binding, and biological evaluation of water-solublehybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders, J MED CHEM, 44(16), 2001, pp. 2536-2543
We have synthesized and evaluated a series of hybrids, denoted 22-27, for i
n vitro cytotoxic activity against a variety of cancer cell lines. These hy
brids represent a molecular combination of polypyrrole minor groove binders
structurally related to the natural antitumor agent distamycin A and two p
yrazole analogues of the left-hand segment called cyclopropylpyrroloindole
(CPI) of the potent antitumor antibiotic (+)-CC-1065. These novel water-sol
uble hybrids have been designed to enhance the minor groove binding ability
of alkylating units 20 and 21, which should increase their clinical appeal
by overcoming the administration problems of (+)CC-1065 derivatives. The D
NA alkylating and cytotoxic activities against several tumor cell lines are
reported and discussed in terms of their structural differences in relatio
n to both the number of N-methyl pyrrole rings and the type of the alkylati
ng unit tethered to the oligopeptidic frame. It may be noted that, in gener
al, and especially for 22-24, the cytotoxicity of the hybrids was much grea
ter than that of the alkylating units alone. In only one case, compound 27,
did the hybrid have cytotoxic activity comparable to that of the alkylatin
g unit alone against FM3A/0 cells. The broadest spectrum of activity and gr
eatest potency was shown by the hybrid 24, in which the alkylating unit 20
and the deformyl distamycin A are tethered by 1-methyl 2,5-dicarbonyl pyraz
ole, with IC50 values for the different tumor cell lines ranging from 7 to
71 nM. For compounds 22-24, the increase of the length of the pseudopeptidi
c moiety from one to three N-methylpyrrole residues led to an increased cyt
otoxicity. Among the hybrids tested for their inhibitory effects on the pro
liferation of murine L1210 leukemia cell line, compound 24 proved to be the
most active (IC50 = 7.4 nM), and in the sequencing gel experiments, it sho
wed the strongest and most highly sequence-specific DNA alkylation activity
. For compounds 22-24, the sequence specificity of DNA alkylation appears t
o be affected by the modification of the number of pyrrole rings, and the c
orrelation between cytotoxicity and alkylation pattern suggests that 24 exe
rts its cytotoxicity through DNA sequence-specific alkylation of the third
adenine located in the sequence 5 ' -ACAAAAATCG-3 '. The two other hybrids
22 and 23 were slightly less active for tumor cell proliferation, with IC50
values of 58 and 19 nM, respectively. With only one exception, none of the
compounds was endowed with antiviral activity at subtoxic concentrations.
Compound 24 inhibited the effect of vaccinia virus at a concentration that
was significantly lower than its minimum cytotoxic concentration for the E6
SM host cells. These compounds gave distinct patterns of alkylation in AT-r
ich sequences, indicating that minor structural changes produced marked alt
erations in sequence selectivity.